Life Lessons
Artfully Adapting Your Media Outreach Strategy To Weather Uncertain Times
To say that these are unprecedented times is an understatement. How do we go about media relations at a time like this? Here are six ways to adapt your media outreach through mutual respect and kindness.
Read More
Kick-Ass Ambassadors of Science and Technology That CG Life Looks Up To
In recognition of Women’s History Month and International Women’s Day 2020, the CG Life team shares personal stories about Women in STEM that inspire our team.
Read More
With Coronavirus Uncertainties, What Is Your Trade Show Contingency Plan?
Do you have a trade show and conference contingency plan in preparation for coronavirus cancelations? Check out our top recommendations for pivoting your marketing in a new, fruitful direction during this uncertain period.
Read More
2020 Excitement and Digital Intrigue at CG Life: What Will this Year Bring?
CG Life’s multi-disciplinary marketing & communications team discusses what events, trends, & practices they are excited for in 2020.
Read More
CG Life Brings a New Element to the Table
As you may have heard, The Market Element is now a CG Life company! The convergence of these two agencies represents…
Read More
14 Avenues for Establishing Thought Leadership in Science
Thought-leadership campaigns can sometimes appear to have a deceptively simple recipe: Mix one part KOL with a strong overarching narrative and…
Read More
Recent Trends in R&D Spending: The Landscape of Private Investment in Science
Private investment in science plays a growing role in R&D, especially in the US. Learn more about this trend in our overview of private R&D spending.
Read More
Private Investment and Science: How Marketing & Communications Can Bridge Two Worlds
To encourage science funding and guide investor groups towards successful investment (either for the first time or to expand their existing portfolio), we discuss a few common pitfalls encountered when these worlds collide and how a science marketing and communications strategy often functions as a natural interface between investors and scientific founders.
Read More
Accelerating the Demise of Science Marketing Clichés
We’re all guilty of at least one or two corny science marketing infringements, but some of us really lean into it. You know who you are. You’re so busy ‘accelerating’ ‘cutting-edge’ research and highlighting ‘novel and robust’ data that you don’t have time to birth something a bit different. We get it. So, what’s the solution?
Read More
Clinical Trial Branding: It’s Time to Ditch the License Plate Numbers
There’s a business case to be made for naming and branding a lot of clinical trials. But below, we dive into one aspect of the discussion: How changes to the way clinical trials are being run are increasing the pressure – and the incentives around – naming and branding yours.
Read More